Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

University of Victoria

$25,000.00

A microfluidic printhead for printing photo-cross linkable hydrogels

FY 2017-18

Summary
The demand for organ repair and transplantation, and a shortage of available donors necessitates the clinicalneed to develop innovative treatment strategies for long-term repair and regeneration of injured or diseasedtissues and organs. 3D printing is a process used to construct 3D objects by relying on the layer-by-layerdeposition of materials onto a computer-controlled build platform. Bioprinting combines 3D printingtechnology, cell biology, and materials science, by coupling the build platform with a device that enables thedeposition of bioinks. Bioprinting technology is adaptive to a wide range of biomaterials (i.e., synthetic andnatural polymers, blood-derived proteins, and de-cellularized extracellular matrix (ECM)), accommodating thegrowth and proliferation of various cell sources, including stem cells and somatic cells. Aspect Biosystems'proprietary Lab-on-PrinterTM technology utilizes the concept of coaxial-flow focusing to deposit cell-ladenbiological fibers layer-by-layer and form 3D tissue-like constructs. Aspect Biosystems is planning to extendtheir Bioink library to include photo-crosslinkable materials including gelatin methacryloyl (GelMA) andpolyethylene glycol diacrylate (PEGDA). Lab-on- a-PrinterTM technology is compatible with a range of lowand medium viscosity Bioinks that are particularly well suited to promoting tissue function due to acombination of favorable mechanical properties and high ratios of bioactive and cellular content to scaffoldcomponents. Using these materials can significantly improve the printing resolution which will lead to bettercontrol on the micro- and macrostructure of the fabricated scaffolds. The overarching goals of this Engageproject are to modify the current printhead cartridges to print photo-crosslinkable gelatin as a widely usedbiomaterial in the tissue engineering community. We will perform a systematic characterization study todevelop a protocol for the fabrication of photo-crosslinkable hydrogel constructs. Cells will be loaded in thefabricated constructs to evaluate the biocompatibility of the process.
Program
Engage Grants Program
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
520820-2017
Name nom
Akbari, Mohsen
Department département
Mechanical Engineering
Organization id
7
Institution établissement
University of Victoria
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
1
Nb partie
1
Application title
A microfluidic printhead for printing photo-cross linkable hydrogels
Keyword
NSERC
Application summary
The demand for organ repair and transplantation, and a shortage of available donors necessitates the clinicalneed to develop innovative treatment strategies for long-term repair and regeneration of injured or diseasedtissues and organs. 3D printing is a process used to construct 3D objects by relying on the layer-by-layerdeposition of materials onto a computer-controlled build platform. Bioprinting combines 3D printingtechnology, cell biology, and materials science, by coupling the build platform with a device that enables thedeposition of bioinks. Bioprinting technology is adaptive to a wide range of biomaterials (i.e., synthetic andnatural polymers, blood-derived proteins, and de-cellularized extracellular matrix (ECM)), accommodating thegrowth and proliferation of various cell sources, including stem cells and somatic cells. Aspect Biosystems'proprietary Lab-on-PrinterTM technology utilizes the concept of coaxial-flow focusing to deposit cell-ladenbiological fibers layer-by-layer and form 3D tissue-like constructs. Aspect Biosystems is planning to extendtheir Bioink library to include photo-crosslinkable materials including gelatin methacryloyl (GelMA) andpolyethylene glycol diacrylate (PEGDA). Lab-on- a-PrinterTM technology is compatible with a range of lowand medium viscosity Bioinks that are particularly well suited to promoting tissue function due to acombination of favorable mechanical properties and high ratios of bioactive and cellular content to scaffoldcomponents. Using these materials can significantly improve the printing resolution which will lead to bettercontrol on the micro- and macrostructure of the fabricated scaffolds. The overarching goals of this Engageproject are to modify the current printhead cartridges to print photo-crosslinkable gelatin as a widely usedbiomaterial in the tissue engineering community. We will perform a systematic characterization study todevelop a protocol for the fabrication of photo-crosslinkable hydrogel constructs. Cells will be loaded in thefabricated constructs to evaluate the biocompatibility of the process.